FDA EIR - Oklahoma Blood Institute - IRB - February 27, 2006

FDA EIR for Oklahoma Blood Institute - IRB on February 27, 2006. Product: Biologics. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA EIR for Oklahoma Blood Institute - IRB on February 27, 2006. Product: Biologics. Access full analysis and detailed observations.

Violation Codes

21 CFR 812

21 CFR 56.115(a)(1)

21 CFR 56.110

None

21 CFR 211.192

21 CFR 56.108

21 CFR 56.109(e)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Oklahoma Blood Institute - IRB

Inspection Date

February 27, 2006

Product Type

Biologics

Office

Dallas District Office

People

Margaret M. Annes

ID: a3b190bd-5fef-4259-a242-64c51b1511a0

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox